Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition). - Zhao B; Zhou X; Zheng P; Zhang B; Feng X; Chen J; Cai L; Chen Y; He L; Su J; Cheng S; Zeng Y; et al. (Frontiers in pharmacology, 2024)